Segmed, a medical technology startup that consolidates imaging data to accelerate AI development, has raised $10.4 million in Series A funding round to expand its footprint in healthcare AI and avail imaging data to health sciences and biopharmaceuticals.
Co-founded in 2017 by Martin Willemink, Adam Koszek, and Jie Wu, the company streamlines researchers’ access to imaging studies to accelerate the development of innovative medical AI tools. It acquires imaging data and de-identifies, standardizes, and provides it to innovators and researchers through its proprietary platform.
Segmed’s latest funding round was spearheaded by 67-hospital Advocate Health and iGan Partners, with significant support from other investors, including Fox Chase Cancer Center and Advocate Health, alongside existing investors, including Y Combinator.
Martin Willemink, CEO and Co-founder of Segmed Inc., said the company focuses on improving patient experience by transforming medical imaging research using high-quality imaging data.
The company boasts an extensive network of healthcare providers sharing imaging data that can be associated with other types of available information to create a pool of valuable data sets for healthcare innovations.
As of Tuesday, September 3, the company had partnered with thousands of healthcare facilities and imaging centers from across five continents, allowing clients access to vital imaging data that they can use to build imaging datasets within the company’s environment.
